Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Hormonally Balanced vs Mevo Health

Hormonally Balanced
Graded #412

Lower grade

vs+3.8000000000000043
Mevo Health
Graded #326

Higher grade

The verdict

Mevo Health takes it — 60.2/100 to 56.4/100.

Mevo Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Mevo Health (Mevo Health LLC, Delaware) is a direct-pay telehealth platform offering compounded semaglutide and tirzepatide in both injection and oral-tablet forms — a rare both-routes, both-molecules menu.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueMevo Health +11
45
56
Dose & formulationMevo Health +43
40
83
Clinical oversightHormonally Balanced +13
80
67
Labs & monitoringHormonally Balanced +1
53
52
FulfillmentHormonally Balanced +16
73
57
Contract termsHormonally Balanced +35
55
20
Hormonally Balanced · left barMevo Health · right bar

The numbers

MetricHormonally BalancedMevo Health
WeighScore56.4/10060.2/100
GradeCC
Scorecard rank#412#326
SemaglutideNot disclosed$199/mo (all doses, compounded)
TirzepatideNot disclosed$259/mo (all doses, compounded)
CoverageAll 50 statesCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyYes
Hormonally Balanced

Graded #412 · C

Strengths

  • Physician-led women's hormone clinic with concierge model
  • Nationwide telehealth availability
  • Semaglutide integrated with hormone care for women
  • Named physician (Dr. Zachareas) oversees prescriptions

Where it loses points

  • No pricing published online; must call or submit a form
  • Weight loss is secondary to menopause/hormone focus
  • Semaglutide only; no tirzepatide listed
  • Compounded vs brand formulation not disclosed
Mevo Health

Graded #326 · C

Strengths

  • LegitScript verification badge on multiple pages
  • Publishes the FDA compounded-medication disclaimer
  • Four named board-certified physicians disclosed (Wasef, Suppa, Sakla, Chikando)
  • Both semaglutide and tirzepatide in injection and oral-tablet forms — rare in DTC
  • Public entry-level pricing surfaced

Where it loses points

  • States served not listed on any public page
  • Pharmacy partners not named (only '503A U.S. compounding pharmacies' with unlabeled logos)
  • No formal Medical Director role disclosed
  • Only 'as low as' entry pricing shown — no per-dose itemization
  • No SOC 2 certification claimed

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard